As Sanofi’s Dupixent rolls on, influenza sales are icing on the cake zbecker Fri, 10/28/2022 – 11:15 More: As Sanofi's Dupixent rolls on, influenza sales are icing on the cake Source: fierce
read moreAbbVie expects Skyrizi, Rinvoq to eclipse Humira’s sales peak, CEO Gonzalez says fkansteiner Fri, 10/28/2022 – 09:56 More: AbbVie expects Skyrizi, Rinvoq to eclipse Humira's sales peak, CEO Gonzalez says Source: fierce
read moreGilead hits surprise FDA rejection for hepatitis D drug already authorized in Europe for 2 years kdunleavy Fri, 10/28/2022 – 09:53 More: Gilead hits surprise FDA rejection for hepatitis D drug already authorized in Europe for 2 years Source: fierce
read moreEMA cracks down on JAK inflammatory disease drugs, limiting AbbVie’s Rinvoq and more on safety risks aliu Fri, 10/28/2022 – 09:43 More: EMA cracks down on JAK inflammatory disease drugs, limiting AbbVie's Rinvoq and more on safety risks Source: fierce
read moreAfter FDA defeat, Oncopeptides trots out small Pepaxto study but assumes it’s not enough to sway the agency kdunleavy Fri, 10/28/2022 – 07:26 More: After FDA defeat, Oncopeptides trots out small Pepaxto study but assumes it’s not enough to sway
read moreTB deaths increase for second year in a row and cases rise for the first time in 20 years More: Stop TB Partnership sounds the alarm on tuberculosis funding crisis Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals